Mouse models of human chromosomal translocations and approaches to cancer therapy.
Cancer arises because of genetic changes in somatic cells, eventually giving rise to overt malignancy. Principle among genetic changes found in tumor cells are chromosomal translocations which give rise to fusion genes or enforced oncogene expression. These mutations are tumor-specific and result in...
Κύριοι συγγραφείς: | Rabbitts, T, Appert, A, Chung, G, Collins, E, Drynan, L, Forster, A, Lobato, M, McCormack, M, Pannell, R, Spandidos, A, Stocks, MR, Tanaka, T, Tse, E |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2001
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer.
ανά: Forster, A, κ.ά.
Έκδοση: (2003) -
The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development.
ανά: McCormack, M, κ.ά.
Έκδοση: (2003) -
Modeling chromosomal translocations using conditional alleles to recapitulate initiating events in human leukemias.
ανά: Lobato, M, κ.ά.
Έκδοση: (2008) -
Chromosomal translocation engineering to recapitulate primary events of human cancer.
ανά: Forster, A, κ.ά.
Έκδοση: (2005) -
Mouse Af9 is a controller of embryo patterning, like Mll, whose human homologue fuses with Af9 after chromosomal translocation in leukemia.
ανά: Collins, E, κ.ά.
Έκδοση: (2002)